Healthcare Sector Review: Winning and :Losing Stocks on Nov 22nd

Wall St. Watchdog reveals information about today’s action in the Healthcare (NYSE:XLV) sector:

Gainers (% price change)

  • ZIOPHARM Oncology Inc. (NASDAQ:ZIOP): The shares closed at $4.80, up $0.49, or 11.37%, on the day. Its market capitalization is $328.57 million. About the company: ZIOPHARM Oncology, Inc. is a biopharmaceutical company seeking to acquire, develop and commercialize a diverse, risk-sensitive portfolio of in-licensed cancer drugs. Get the most recent company news and stock data here >>
  • Delcath Systems, Inc. (NASDAQ:DCTH): The shares closed at $2.62, up $0.22, or 9.17%, on the day. Its market capitalization is $125.74 million. About the company: Delcath Systems Inc. has developed a system to isolate the liver from the circulatory system and to administer chemotherapy and other therapeutic agents directly to the liver. This system filters the patients blood removing most of the harmful chemotherapy agents lessening the side-effects of the treatment. Get the most recent company news and stock data here >>
  • Cambrex Corporation (NYSE:CBM): The shares closed at $6.31, up $0.46, or 7.86%, on the day. Its market capitalization is $185.72 million. About the company: Cambrex Corp. supplies products, services, and technologies for the Life Sciences and fine chemicals industry. The Company builds platforms for use in manufacturing small molecule Active Pharmaceutical Ingredients (APIs) and pharmaceutical intermediates including drug delivery. Cambrex’s services include process & analytical development, scale-up in addition to generic APIs. Get the most recent company news and stock data here >>
  • Akorn, Inc. (NASDAQ:AKRX): The shares closed at $9.63, up $0.66, or 7.36%, on the day. Its market capitalization is $911.79 million. About the company: Akorn, Inc. develops, manufactures, and markets ophthalmic and injectable pharmaceutical products. The Company sells various diagnostic and therapeutic pharmaceutical products focused primarily on ophthalmology, anesthesia, antidotes, and rheumatology. Akorn also markets ophthalmic surgical instruments and other supplies, and provides contract manufacturing for third parties. Get the most recent company news and stock data here >>
  • Gilead Sciences, Inc. (NASDAQ:GILD): The shares closed at $38.76, up $2.5, or 6.89%, on the day. Its market capitalization is $29.11 billion. About the company: Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops, and commercializes therapeutics to advance the care of patients suffering from life-threatening diseases. The Company’s primary arees of focus include HIV/AIDS, liver disease and serious cardiovascular and respiratory conditions. Get the most recent company news and stock data here >>

Losers (% price change)

  • Infinity Pharmaceuticals (NASDAQ:INFI): The shares closed at $7.40, down $0.6, or 7.5%, on the day. Its market capitalization is $197.42 million. About the company: Infinity Pharmaceuticals, Inc. researches and develops cancer drugs. The Company uses small molecule drug technologies in the development of its products. Get the most recent company news and stock data here >>
  • Savient Pharmaceuticals (NASDAQ:SVNT): The shares closed at $2.35, down $0.17, or 6.75%, on the day. Its market capitalization is $167.96 million. About the company: Savient Pharmaceuticals Inc. develops, manufactures, and markets human health care products for niche and wider markets. The Company offers pharmaceutical products for a wide range of medical needs such as weight gain, drugs targeting the control of elevated uric acid levels in the blood, and rheumatology. Get the most recent company news and stock data here >>
  • GTx, Inc. (NASDAQ:GTXI): The shares closed at $2.72, down $0.19, or 6.53%, on the day. Its market capitalization is $170.79 million. About the company: GTx, Inc. discovers, develops, and commercializes therapeutics primarily related to the treatment of serious men’s health conditions. The Company’s drug discover and development programs are focused on small molecules that selectively modulate the effects of estrogens and androgens, two essential classes of hormones. GTx is currently developing products for prostate cancer. Get the most recent company news and stock data here >>
  • Amedisys, Inc. (NASDAQ:AMED): The shares closed at $10.37, down $0.71, or 6.41%, on the day. Its market capitalization is $311.41 million. About the company: Amedisys, Inc. is a multi-regional provider of alternate-site health care services. The Company offers home health care nursing, home infusion therapy, and ambulatory surgery centers. Amedisys operates offices within a network of subsidiaries in the southern and southeastern United States. Get the most recent company news and stock data here >>
  • Cleveland BioLabs, Inc. (NASDAQ:CBLI): The shares closed at $2.84, down $0.18, or 5.96%, on the day. Its market capitalization is $100.85 million. About the company: Cleveland Biolabs, Inc. develops pharmaceuticals. The Company develops drugs to protect humans from exposure to radiation. Get the most recent company news and stock data here >>

(Note: Selected financial data are sourced from Google Finance. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>

More from The Cheat Sheet